PMID- 17565707 OWN - NLM STAT- MEDLINE DCOM- 20070906 LR - 20131121 IS - 1932-8451 (Print) IS - 1932-8451 (Linking) VI - 67 IP - 8 DP - 2007 Jul TI - L-type calcium channels mediate acetylcholine receptor aggregation on cultured muscle. PG - 987-98 AB - Agrin activation of muscle specific kinase (MuSK) initiates postsynaptic development on skeletal muscle that includes the aggregation of acetylcholine receptors (AChRs; Glass et al. [1996]: Cell 85: 513-523; Gautam et al. [1996]: Cell 85: 525-535). Although the agrin/MuSK signaling pathway remains largely unknown, changes in intracellular calcium levels are required for agrin-induced AChR aggregation (Megeath and Fallon [1998]: J Neurosci 18: 672-678). Here, we show that L-type calcium channels (L-CaChs) are required for full agrin-induced aggregation of AChRs and sufficient to induce agrin-independent AChR aggregation. Blockade of L-CaChs in muscle cultures inhibited agrin-induced AChR aggregation but not tyrosine phosphorylation of MuSK or AChR beta subunits. Activation of L-CaChs in the absence of agrin induced AChR aggregation but not tyrosine phosphorylation of MuSK or AChR beta subunits. Agrin responsiveness was significantly reduced in primary muscle cultures from the muscular dysgenesis mouse, a natural mutant, which does not express the L-CaCh. Our results establish a novel role for L-CaChs as important sources of the intracellular calcium necessary for the aggregation of AChRs. CI - Copyright (c) 2007 Wiley Periodicals, Inc. FAU - Milholland, Rebecca B R AU - Milholland RB AD - Department of Cell Biology and Anatomy, University of Arizona Health Sciences Center, Tucson, Arizona 85724-5044, USA. FAU - Dulla, Christopher AU - Dulla C FAU - Gordon, Herman AU - Gordon H LA - eng GR - T35 HL07479/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. PL - United States TA - Dev Neurobiol JT - Developmental neurobiology JID - 101300215 RN - 0 (Agrin) RN - 0 (Calcium Channels, L-Type) RN - 0 (Receptors, Cholinergic) RN - 21820-51-9 (Phosphotyrosine) RN - EC 2.7.10.1 (MuSK protein, mouse) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) RN - I9ZF7L6G2L (Nifedipine) SB - IM MH - Agrin/pharmacology MH - Animals MH - Calcium Channels, L-Type/drug effects/*physiology MH - Cells, Cultured MH - Genotype MH - Mice MH - Muscle, Skeletal/abnormalities/cytology/*physiology MH - Nifedipine/pharmacology MH - Phosphorylation MH - Phosphotyrosine/metabolism MH - Polymerase Chain Reaction MH - Rats MH - Receptor Protein-Tyrosine Kinases/metabolism MH - Receptors, Cholinergic/drug effects/*physiology EDAT- 2007/06/15 09:00 MHDA- 2007/09/07 09:00 CRDT- 2007/06/15 09:00 PHST- 2007/06/15 09:00 [pubmed] PHST- 2007/09/07 09:00 [medline] PHST- 2007/06/15 09:00 [entrez] AID - 10.1002/dneu.20397 [doi] PST - ppublish SO - Dev Neurobiol. 2007 Jul;67(8):987-98. doi: 10.1002/dneu.20397.